AHMAD EL-FAR M.D. NPI 1811209380

NPI Information

  • NPI: 1811209380
  • Provider Name: AHMAD EL-FAR, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 325 1ST ST N
    WINTER HAVEN, FL
    ZIP 33881
  • Phone: (863) 293-1191

Map and Directions

Get Directions

NPI Details

Ahmad El-far, M.D. is a hematology and oncology internal medicine in Winter Haven, FL with 18 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Ahmad El-far, M.D. NPI is 1811209380. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

325 1ST ST N
WINTER HAVEN, FL
ZIP 33881-111
Phone: (863) 293-1191

The NPI 1811209380 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
  • Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, heparin sodium, (heparin lock flush), per 10 units (HCPCS:J1642)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Uric acid level, blood (HCPCS:84550)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Infusion, normal saline solution, 250 cc (HCPCS:J7050)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Transferrin (iron binding protein) level (HCPCS:84466)
  • Iron level (HCPCS:83540)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Folic acid level, serum (HCPCS:82746)
  • Collection of blood sample from implanted device (HCPCS:36591)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Urea nitrogen level to assess kidney function, quantitative (HCPCS:84520)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Blood creatinine level (HCPCS:82565)
  • Testosterone (hormone) level, total (HCPCS:84403)
  • Red blood count, automated test (HCPCS:85045)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Ct scan of abdomen and pelvis before and after contrast (HCPCS:74178)
  • Ct scan of chest before and after contrast (HCPCS:71270)
  • Magnesium level (HCPCS:83735)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
  • Bacterial urine culture (HCPCS:87088)
  • Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
  • Biopsy of bone marrow (HCPCS:38221)
  • Complete ultrasound scan of abdomen (HCPCS:76700)
  • Urinalysis using microscope (HCPCS:81015)

The enumeration date for this NPI number is 7/13/2010 and was last updated on 9/11/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & OncologyME131283FLORIDAYes
2207R00000XInternal Medicine01072570AINDIANANo

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1020430600MEDICAIDFLORIDA

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.